These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 3552590)
1. The role of vasodilator therapy in the treatment of severe chronic heart failure. Packer M Drugs; 1986; 32 Suppl 5():13-26. PubMed ID: 3552590 [TBL] [Abstract][Full Text] [Related]
3. [The extension of heart failure therapy with vasodilators]. Assmann I Z Gesamte Inn Med; 1990 Jun; 45(12):352-6. PubMed ID: 2201132 [TBL] [Abstract][Full Text] [Related]
4. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
5. Aspects on "traditional" vasodilators in the treatment of chronic heart failure. Rydén L; Conradson TB Acta Med Scand Suppl; 1986; 707():85-90. PubMed ID: 3526822 [TBL] [Abstract][Full Text] [Related]
6. Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification. Packer M Drugs; 1982 Jul; 24(1):64-74. PubMed ID: 6125370 [TBL] [Abstract][Full Text] [Related]
7. [Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency]. Weber S; Pailleret JJ; Cattan S; Guérin F; Degeorges M Ann Med Interne (Paris); 1985; 136(3):256-60. PubMed ID: 3927808 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. Colucci WS; Williams GH; Alexander RW; Braunwald E Am J Med; 1981 Jul; 71(1):89-99. PubMed ID: 6166194 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of vasodilators. Part II. Kirsten R; Nelson K; Kirsten D; Heintz B Clin Pharmacokinet; 1998 Jul; 35(1):9-36. PubMed ID: 9673832 [TBL] [Abstract][Full Text] [Related]
10. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations. Remme WJ Cardiovasc Drugs Ther; 1989 Jun; 3(3):375-96. PubMed ID: 2487535 [TBL] [Abstract][Full Text] [Related]
11. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure. Packer M Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957 [TBL] [Abstract][Full Text] [Related]
12. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. Chatterjee K; Parmley WW J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of vasodilators in the treatment of heart failure. Cohn JN J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):135A-138A. PubMed ID: 8376683 [TBL] [Abstract][Full Text] [Related]
15. Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agent. Packer M Am J Med; 1984 Jun; 76(6A):3-13. PubMed ID: 6377886 [TBL] [Abstract][Full Text] [Related]
16. Congestive heart failure: what should be the initial therapy and why? Chatterjee K Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993 [TBL] [Abstract][Full Text] [Related]
17. Congestive heart failure. Drug therapy: central or peripheral approach? Remme WJ Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652 [TBL] [Abstract][Full Text] [Related]
18. [Vasodilator therapy in cardiac failure]. Akatsuka N Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237 [TBL] [Abstract][Full Text] [Related]
19. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?]. Malacco E; Limonta A; Milanesi A; Micossi P Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000 [TBL] [Abstract][Full Text] [Related]
20. [Conversion enzyme inhibitors in the treatment of chronic congestive cardiac failure. Physiopathologic bases of their use]. Garabedian VG Presse Med; 1985 Dec; 14(44):2264-7. PubMed ID: 3003732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]